Global Novel Coronavirus (COVID-19) Vaccine Market Growth (Status and Outlook) 2023-2028

Report ID: 1292046 | Published Date: Jan 2025 | No. of Page: 105 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Novel Coronavirus (COVID-19) Vaccine Market Size 2022-2028
        2.1.2 Novel Coronavirus (COVID-19) Vaccine Market Size CAGR by Region
    2.2 Novel Coronavirus (COVID-19) Vaccine Segment by Type
        2.2.1 DNA
        2.2.2 RNA
        2.2.3 Others
    2.3 Novel Coronavirus (COVID-19) Vaccine Market Size by Type
        2.3.1 Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Type (2022-2028)
        2.3.2 Global Novel Coronavirus (COVID-19) Vaccine Market Size Growth Rate by Type (2022-2028)
    2.4 Novel Coronavirus (COVID-19) Vaccine Segment by Application
        2.4.1 Mild Symptom Patient
        2.4.2 Critically Ill Patient
    2.5 Novel Coronavirus (COVID-19) Vaccine Market Size by Application
        2.5.1 Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application (2022-2028)
        2.5.2 Global Novel Coronavirus (COVID-19) Vaccine Market Size Growth Rate by Application (2022-2028)
3 Novel Coronavirus (COVID-19) Vaccine Key Players
    3.1 Date of Key Players Enter into Novel Coronavirus (COVID-19) Vaccine
    3.2 Key Players Novel Coronavirus (COVID-19) Vaccine Product Offered
    3.3 Key Players Novel Coronavirus (COVID-19) Vaccine Funding/Investment Analysis
    3.4 Funding/Investment
        3.4.1 Funding/Investment by Regions
        3.4.2 Funding/Investment by End-Industry
    3.5 Key Players Novel Coronavirus (COVID-19) Vaccine Valuation & Market Capitalization
    3.6 Key Players Mergers & Acquisitions, Expansion Plans
    3.7 Market Ranking
    3.8 New Product/Technology Launches
    3.9 Partnerships, Agreements, and Collaborations
    3.10 Mergers and Acquisitions
4 Novel Coronavirus (COVID-19) Vaccine by Regions
    4.1 Novel Coronavirus (COVID-19) Vaccine Market Size by Regions (2022-2028)
    4.2 United States Novel Coronavirus (COVID-19) Vaccine Market Size Growth (2022-2028)
    4.3 China Novel Coronavirus (COVID-19) Vaccine Market Size Growth (2022-2028)
    4.4 Europe Novel Coronavirus (COVID-19) Vaccine Market Size Growth (2022-2028)
    4.5 Rest of World Novel Coronavirus (COVID-19) Vaccine Market Size Growth (2022-2028)
5 United States
    5.1 United States Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2022-2028)
    5.2 United States Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2022-2028)
6 China
    6.1 China Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2022-2028)
    6.2 China Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2022-2028)
7 Europe
    7.1 Europe Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2022-2028)
    7.2 Europe Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2022-2028)
8 Rest of World
    8.1 Rest of World Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2022-2028)
    8.2 Rest of World Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2022-2028)
    8.3 Japan
    8.4 South Korea
    8.5 Southeast Asia
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Key Investors in Novel Coronavirus (COVID-19) Vaccine
    10.1 Company A
        10.1.1 Company A Company Details
        10.1.2 Company Description
        10.1.3 Companies Invested by Company A
        10.1.4 Company A Key Development and Market Layout
    10.2 Company B
        10.2.1 Company B Company Details
        10.2.2 Company Description
        10.2.3 Companies Invested by Company B
        10.2.4 Company B Key Development and Market Layout
    10.3 Company C
        10.3.1 Company C Company Details
        10.3.2 Company Description
        10.3.3 Companies Invested by Company C
        10.3.4 Company C Key Development and Market Layout
    10.4 Company D
    10.5 ……
11 Key Players Analysis
    11.1 Inovio Pharmaceuticals
        11.1.1 Inovio Pharmaceuticals Company Details
        11.1.2 Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product Offered
        11.1.3 Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
        11.1.4 Inovio Pharmaceuticals Main Business Overview
        11.1.5 Inovio Pharmaceuticals News
    11.2 Takis Biotech (Evvivax)
        11.2.1 Takis Biotech (Evvivax) Company Details
        11.2.2 Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Product Offered
        11.2.3 Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
        11.2.4 Takis Biotech (Evvivax) Main Business Overview
        11.2.5 Takis Biotech (Evvivax) News
    11.3 Zydus Cadila
        11.3.1 Zydus Cadila Company Details
        11.3.2 Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Product Offered
        11.3.3 Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
        11.3.4 Zydus Cadila Main Business Overview
        11.3.5 Zydus Cadila News
    11.4 Codagenix, Inc.
        11.4.1 Codagenix, Inc. Company Details
        11.4.2 Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Product Offered
        11.4.3 Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
        11.4.4 Codagenix, Inc. Main Business Overview
        11.4.5 Codagenix, Inc. News
    11.5 GeoVax, Inc.
        11.5.1 GeoVax, Inc. Company Details
        11.5.2 GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Product Offered
        11.5.3 GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
        11.5.4 GeoVax, Inc. Main Business Overview
        11.5.5 GeoVax, Inc. News
    11.6 Bravovax
        11.6.1 Bravovax Company Details
        11.6.2 Bravovax Novel Coronavirus (COVID-19) Vaccine Product Offered
        11.6.3 Bravovax Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
        11.6.4 Bravovax Main Business Overview
        11.6.5 Bravovax News
    11.7 Janssen Pharmaceutical Companies
        11.7.1 Janssen Pharmaceutical Companies Company Details
        11.7.2 Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Product Offered
        11.7.3 Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
        11.7.4 Janssen Pharmaceutical Companies Main Business Overview
        11.7.5 Janssen Pharmaceutical Companies News
    11.8 Altimmune
        11.8.1 Altimmune Company Details
        11.8.2 Altimmune Novel Coronavirus (COVID-19) Vaccine Product Offered
        11.8.3 Altimmune Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
        11.8.4 Altimmune Main Business Overview
        11.8.5 Altimmune News
    11.9 Vaxart
        11.9.1 Vaxart Company Details
        11.9.2 Vaxart Novel Coronavirus (COVID-19) Vaccine Product Offered
        11.9.3 Vaxart Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
        11.9.4 Vaxart Main Business Overview
        11.9.5 Vaxart News
    11.10 CanSino Biologics
        11.10.1 CanSino Biologics Company Details
        11.10.2 CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Product Offered
        11.10.3 CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
        11.10.4 CanSino Biologics Main Business Overview
        11.10.5 CanSino Biologics News
    11.11 ExpreS2ion Biotechnologies ApS
    11.12 Clover Biopharmaceuticals
    11.13 GSK
    11.14 Vaxil Bio Ltd.
    11.15 Generex
    11.16 Novavax, Inc.
    11.17 Sanofi Pasteur
    11.18 Baylor
    11.19 iBio, Inc.
    11.20 Moderna, Inc.
    11.21 Curevac
    11.22 ImmunoPrecise
12 Research Findings and Conclusion

List of Tables
    Table 1. Novel Coronavirus (COVID-19) Vaccine Market Size CAGR by Region (2022-2028) ($ Millions)
    Table 2. Major Players of DNA
    Table 3. Major Players of RNA
    Table 4. Major Players of Others
    Table 5. Global Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2022-2028) ($ Millions)
    Table 6. Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Type (2022-2028)
    Table 7. Global Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2022-2028) ($ Millions)
    Table 8. Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application (2022-2028)
    Table 9. Date of Global Key Players Enter into Novel Coronavirus (COVID-19) Vaccine Market
    Table 10. Global Key Players Novel Coronavirus (COVID-19) Vaccine Product Offered
    Table 11. Key Players Novel Coronavirus (COVID-19) Vaccine Funding/Investment ($ Millions)
    Table 12. Funding/Investment by Regions
    Table 13. Funding/Investment by End Industry
    Table 14. Key Players Novel Coronavirus (COVID-19) Vaccine Valuation & Market Capitalization ($ Millions)
    Table 15. Key Players Mergers & Acquisitions, Expansion Plans
    Table 16. Novel Coronavirus (COVID-19) Vaccine New Product/Technology Launches
    Table 17. Novel Coronavirus (COVID-19) Vaccine Industry Partnerships, Agreements, and Collaborations
    Table 18. Novel Coronavirus (COVID-19) Vaccine Industry Mergers and Acquisitions
    Table 19. Global Novel Coronavirus (COVID-19) Vaccine Market Size by Regions 2022-2028 ($ Millions)
    Table 20. Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Regions 2022-2028
    Table 21. United States Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2022-2028) ($ Millions)
    Table 22. United States Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Type (2022-2028)
    Table 23. United States Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2022-2028) ($ Millions)
    Table 24. United States Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application (2022-2028)
    Table 25. China Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2022-2028) ($ Millions)
    Table 26. China Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Type (2022-2028)
    Table 27. China Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2022-2028) ($ Millions)
    Table 28. China Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application (2022-2028)
    Table 29. Europe Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2022-2028) ($ Millions)
    Table 30. Europe Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Type (2022-2028)
    Table 31. Europe Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2022-2028) ($ Millions)
    Table 32. Europe Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application (2022-2028)
    Table 33. Rest of World Novel Coronavirus (COVID-19) Vaccine Market Size by Type (2022-2028) ($ Millions)
    Table 34. Rest of World Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Type (2022-2028)
    Table 35. Rest of World Novel Coronavirus (COVID-19) Vaccine Market Size by Application (2022-2028) ($ Millions)
    Table 36. Rest of World Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application (2022-2028)
    Table 37. Key Market Drivers & Growth Opportunities of Novel Coronavirus (COVID-19) Vaccine
    Table 38. Key Market Challenges & Risks of Novel Coronavirus (COVID-19) Vaccine
    Table 39. Key Industry Trends of Novel Coronavirus (COVID-19) Vaccine
    Table 40. Company A Company Details
    Table 41. Companies Invested by Company A
    Table 42. Company A Key Development and Market Layout
    Table 43. Company B Company Details
    Table 44. Companies Invested by Company B
    Table 45. Company B Key Development and Market Layout
    Table 46. Company C Company Details
    Table 47. Companies Invested by Company C
    Table 48. Company C Key Development and Market Layout
    Table 49. Company C Company Details
    Table 50. Companies Invested by Company C
    Table 51. Company C Key Development and Market Layout
    Table 52. Inovio Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 53. Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 54. Takis Biotech (Evvivax) Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 55. Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 56. Zydus Cadila Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 57. Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 58. Codagenix, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 59. Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 60. GeoVax, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 61. GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 62. Bravovax Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 63. Bravovax Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 64. Janssen Pharmaceutical Companies Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 65. Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 66. Altimmune Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 67. Altimmune Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 68. Vaxart Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 69. Vaxart Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 70. CanSino Biologics Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 71. CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 72. ExpreS2ion Biotechnologies ApS Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 73. ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 74. Clover Biopharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 75. Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 76. GSK Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 77. GSK Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 78. Vaxil Bio Ltd. Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 79. Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 80. Generex Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 81. Generex Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 82. Novavax, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 83. Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 84. Sanofi Pasteur Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 85. Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 86. Baylor Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 87. Baylor Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 88. iBio, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 89. iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 90. Moderna, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 91. Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 92. Curevac Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 93. Curevac Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
    Table 94. ImmunoPrecise Basic Information, Head Office, Major Market Areas and Its Competitors
    Table 95. ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Market Size (2022 VS 2027)
List of Figures
    Figure 1. Picture of Novel Coronavirus (COVID-19) Vaccine
    Figure 2. Novel Coronavirus (COVID-19) Vaccine Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Novel Coronavirus (COVID-19) Vaccine Market Size Growth Rate 2022-2028 ($ Millions)
    Figure 7. Novel Coronavirus (COVID-19) Vaccine Market Size by Region (2022 & 2027) ($ millions)
    Figure 8. Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Type (2022-2028)
    Figure 9. Global DNA Market Size Growth Rate
    Figure 10. Global RNA Market Size Growth Rate
    Figure 11. Global Others Market Size Growth Rate
    Figure 12. Novel Coronavirus (COVID-19) Vaccine in Mild Symptom Patient
    Figure 13. Global Novel Coronavirus (COVID-19) Vaccine Market: Mild Symptom Patient (2022-2028) ($ Millions)
    Figure 14. Novel Coronavirus (COVID-19) Vaccine in Critically Ill Patient
    Figure 15. Global Novel Coronavirus (COVID-19) Vaccine Market: Critically Ill Patient (2022-2028) ($ Millions)
    Figure 16. Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application (2022-2028)
    Figure 17. Global Novel Coronavirus (COVID-19) Vaccine Market Size in Mild Symptom Patient Growth Rate
    Figure 18. Global Novel Coronavirus (COVID-19) Vaccine Market Size in Critically Ill Patient Growth Rate
    Figure 19. Funding/Investment
    Figure 20. Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Regions 2022-2028
    Figure 21. United States Novel Coronavirus (COVID-19) Vaccine Market Size 2022-2028 ($ Millions)
    Figure 22. China Novel Coronavirus (COVID-19) Vaccine Market Size 2022-2028 ($ Millions)
    Figure 23. Europe Novel Coronavirus (COVID-19) Vaccine Market Size 2022-2028 ($ Millions)
    Figure 24. Rest of World Novel Coronavirus (COVID-19) Vaccine Market Size 2022-2028 ($ Millions)
    Figure 25. United States Novel Coronavirus (COVID-19) Vaccine Consumption Market Share by Type in 2027
    Figure 26. United States Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application in 2027
    Figure 27. China Novel Coronavirus (COVID-19) Vaccine Consumption Market Share by Type in 2027
    Figure 28. China Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application in 2027
    Figure 29. Europe Novel Coronavirus (COVID-19) Vaccine Consumption Market Share by Type in 2027
    Figure 30. Europe Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application in 2027
    Figure 31. Rest of World Novel Coronavirus (COVID-19) Vaccine Consumption Market Share by Type in 2027
    Figure 32. Rest of World Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Application in 2027
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Novel Coronavirus Vaccine Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Novel Coronavirus Vaccine Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Novel Coronavirus Vaccine Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports